Drug Name Ilanris (canakinumab) المجموعة الدوائية Immunosuppressant نوع وسيلة تقليل المخاطر بطاقة المريض Specialty (Theraputic area) Rheumatology المخاطر Infections, Opportunistic infections, Neutropenia, Drug induced liver injury (DILI, hepatic transaminase and bilirubin elevations) (for Still’s disease), Decreased estimated creatinine clearance and proteinuria (for Still’s disease), Musculoskeletal pain and arthralgia (for Still’s disease) بطاقة المريض